Changes in Lymphocyte cell surface markers in human disease states.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology*; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D002454:Cell Differentiation; D005921:Glomerulonephritis / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007158:Immunologic Techniques; D007239:Infections / Q000276:immunology; D007674:Kidney Diseases / Q000276:immunology; D007938:Leukemia / Q000276:immunology; D008107:Liver Diseases / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology; D051379:Mice; D009103:Multiple Sclerosis / Q000276:immunology; D011961:Receptors, Fc / Q000276:immunology; D012213:Rheumatic Fever / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014181:Transplantation Immunology
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D000949:Histocompatibility Antigens Class II; D011961:Receptors, Fc